Generic drugs are not identical to branded versions: fillers, delivery systems, and shelf-life reliability can differ, and producers' incentives to be careful vary, so generics can be an inferior product at a lower price, which reduces willingness to switch.

factualpending

Speaker

Richard Epstein

Evidence Quote

“The incentives that are there for the patented drug maker to be careful aren't necessarily there for the generic producer”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...